ABSTRACT
Background COVID-19 has emerged as a global pandemic, affecting nearly 104 million people worldwide as of February 4th 2021. In previous published studies, the association between the mean Vit D status of each country and COVID-19 infection rate, and mortality among the adult population in European countries was examined. The aim of this study was to re-examine the relationship between the Vit D status of each country and COVID-19 infection, recovery, and mortality using updated data and a different methodological approach.
Methods Information only form the last decade on Vit D concentration/deficiency for each country was retrieved through literature search on PubMed® database. As of February, 4th 2021, COVID-19 infections and mortalities per one million population as well as total recoveries were extracted from the Worldometer website. The association between vitamin D deficiency and COVID-19 infection, recovery, and mortality were explored using correlation coefficients and scatterplots.
Findings The prevalence of vitamin D deficiency among European countries ranged from 6.0 (Finland) to 75.5% (Turkey), with several countries facing more than 50% of vitamin D deficiency among their population. Non-significant correlations were observed between the number of COVID-19 infections (r=0.190; p=0.374), recoveries (rs=0.317, p=0.131), and mortalities (r=0.129; p=0.549) per one million population, with the prevalence of vitamin D deficiency.
Interpretation Prevalence of vitamin D deficiency was not significantly associated with either number of infections, recoveries or mortality rate of COVID-19 among European countries. Thus, it is an important parameter to be considered when implementing preventive measures to face COVID-19.
Funding None
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: dmpakalo{at}auth.gr (D.R. Bakaloudi), mhourd{at}gapps.auth.gr (M. Chourdakis)
Data Availability
Not applicable
ABBREVIATIONS
- 1M
- One million
- 25(OH)D
- 25-hydroxyvitamin D3
- ACE2
- Angiotensin-Converting Enzyme 2
- Ang (1-7)
- Angiotensin (1-7)
- ARS
- Acute Respiratory Syndrome
- COVID-19
- Coronavirus disease 2019
- ECTS
- European Calcified Tissue Society
- ICU
- Intensive Care Unit
- ISO
- International Organization for Standardization
- MasR
- Mas Receptor
- RAS
- Renin - Angiotensin System
- RCT
- Randomized controlled trial
- RICU
- Respiratory Intermediate Care Unit
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus
- UV
- Ultraviolet
- UVB
- Ultraviolet B
- Vit D
- Vitamin D